Philips Receives FDA Clearance for AI-Powered Solution for Minimally Invasive Heart Valve Repair

Philips has received FDA clearance for EchoNavigator R5.0 with DeviceGuide, an AI-powered software solution that assists physicians during minimally invasive mitral valve repair procedures. DeviceGuide integrates with Philips' Azurion platform and uses AI to track and visualize repair devices in real-time, supporting more consistent, efficient, and confidently guided procedures. Developed in collaboration with Edwards Lifesciences, DeviceGuide will be showcased at the American College of Cardiology 2026 meeting.